JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Financials | 10.76% |
| 3 | Healthcare | 10.54% |
| 4 | Consumer Discretionary | 10.27% |
| 5 | Industrials | 6.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Cemex
CX
$16B
| $1.4M | ﹤0.01% |
487,708
-323,578
| -40% | -$759K |
|
3177
Ardelyx
ARDX
$1.05B
| $1.4M | ﹤0.01% |
202,302
+182,187
| +906% | +$1.27M |
|
3178
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.26B
| $1.4M | ﹤0.01% |
52,638
+3,270
| +7% | +$85.2K |
|
3179
AtriCure
ATRC
$2.25B
| $1.4M | ﹤0.01% |
31,050
+18,519
| +148% | +$806K |
|
3180
CALL
CrowdStrike
CRWD
$221B
| $1.38M | ﹤0.01% |
+55,200
| New | +$1.11M |
|
3181
Marcus & Millichap
MMI
$1.2B
| $1.38M | ﹤0.01% |
47,883
+3,054
| +7% | +$86.1K |
|
3182
Talos Energy
TALO
$2.63B
| $1.38M | ﹤0.01% |
150,051
-18,549
| -11% | -$193K |
|
3183
Ameresco
AMRC
$1.48B
| $1.37M | ﹤0.01% |
49,201
-29,351
| -37% | -$592K |
|
3184
Invesco DB Commodity Index Tracking Fund
DBC
$1.73B
| $1.37M | ﹤0.01% |
110,942
-45,464
| -29% | -$525K |
|
|
BSCL
3185
DELISTED
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
| $1.36M | ﹤0.01% |
63,843
+26,236
| +70% | +$559K |
|
3186
Triumph Financial Inc
TFIN
$1.87B
| $1.36M | ﹤0.01% |
56,125
-63,662
| -53% | -$1.56M |
|
3187
Vanguard Short-Term Treasury ETF
VGSH
$30.2B
| $1.36M | ﹤0.01% |
21,869
+16,239
| +288% | +$1.01M |
|
3188
TechTarget
TTGT
$278M
| $1.36M | ﹤0.01% |
45,197
-6,443
| -12% | -$162K |
|
|
YMAB
3189
DELISTED
Y-mAbs Therapeutics
YMAB
| $1.36M | ﹤0.01% |
31,436
-1,035
| -3% | -$39.1K |
|
3190
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
| $1.36M | ﹤0.01% |
22,431
+22,347
| +26,604% | +$1.31M |
|
3191
PUT
Alcon
ALC
$35.9B
| $1.35M | ﹤0.01% |
23,600
+18,200
| +337% | +$1.03M |
|
|
OLP
3192
One Liberty Properties
OLP
$529M
| $1.35M | ﹤0.01% |
76,808
-21,642
| -22% | -$343K |
|
3193
Spero Therapeutics
SPRO
$71.2M
| $1.35M | ﹤0.01% |
99,775
+21,669
| +28% | +$243K |
|
|
PTLA
3194
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.35M | ﹤0.01% |
75,000
| – | – |
|
3195
Axogen
AXGN
$2.62B
| $1.34M | ﹤0.01% |
145,400
-13,980
| -9% | -$125K |
|
3196
B&G Foods
BGS
$294M
| $1.34M | ﹤0.01% |
55,083
+17,764
| +48% | +$385K |
|
3197
PUT
uniQure
QURE
$3.37B
| $1.34M | ﹤0.01% |
+29,800
| New | +$1.76M |
|
3198
PUT
Cedar Fair
FUN
$1.68B
| $1.34M | ﹤0.01% |
+48,800
| New | +$1.39M |
|
|
BRSP
3199
BrightSpire Capital
BRSP
$633M
| $1.34M | ﹤0.01% |
191,079
+15,166
| +9% | +$77.6K |
|
3200
STAAR Surgical
STAA
$1.3B
| $1.34M | ﹤0.01% |
21,758
+4,410
| +25% | +$180K |
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,341 reduced and 399 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 399 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.